版本:
中国

BRIEF-RXI Pharmaceuticals announces initiation of its consumer testing program with RXI-231

June 12 Rxi Pharmaceuticals Corp

* RXI Pharmaceuticals Corp- rxi pharmaceuticals announces initiation of its consumer testing program with rxi-231

* RXI Pharmaceuticals - ‍initiation of consumer/functional testing program with rxi-231, cosmetic ingredient based on sd-rxrna that targets tyrosinase​

* RXI Pharmaceuticals Corp - ‍consumer testing program will evaluate use and consumer acceptability of rxi-231​

* RXI Pharmaceuticals - anticipate duration of combined studies under this program to be about 3-4 months enabling us to report results in q4 of this year Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐